|
|
|
|
|
Legal status
Patent not validated
| (51) | INT.CL. | C07K 14/33 | |
| C12N 1/20 | |||
| C12P 21/02 | |||
| A61K 38/16 |
| (11) | Number of the document | 2454275 |
| (13) | Kind of document | T |
| (96) | European patent application number | 10733117.5 |
| Date of filing the European patent application | 2010-07-12 | |
| (97) | Date of publication of the European application | 2012-05-23 |
| (45) | Date of publication and mention of the grant of the patent | 2017-07-12 |
| (46) | Date of publication of the claims translation |
| (86) | Number | PCT/US2010/041745 |
| Date | 2010-07-12 |
| (87) | Number | WO 2011/008713 |
| Date | 2011-01-20 |
| (30) | Number | Date | Country code |
| 502181 | 2009-07-13 | US |
| (72) |
TON, Jennifer L., US
PATEL, Hemant A., US
BATES, Ronald C., US
AHMAD, Wajdie M., US
|
| (73) |
ALLERGAN, INC.,
2525 Dupont Drive, Irvine, CA 92612,
US
|
| (54) | PROCESS AND SYSTEM FOR OBTAINING BOTULINUM NEUROTOXIN |
| PROCESS AND SYSTEM FOR OBTAINING BOTULINUM NEUROTOXIN |